Researchers found that a popular anti-aging drug combination, dasatinib and quercetin (D+Q), caused significant brain damage in mice. This unexpected outcome raises serious concerns about the safety of this treatment, which has been widely explored for its potential to promote longevity. The study revealed that the drug cocktail led to severe loss of myelin, the protective layer surrounding nerve fibers, and changes in brain cells resembling those seen in multiple sclerosis.

This discovery is particularly relevant for people interested in aging well. Myelin loss can result in symptoms like numbness, pain, and cognitive difficulties, which are not only distressing but may also hinder your ability to maintain an active and fulfilling life. The research showed that younger mice experienced more severe damage than older ones, suggesting that even those in their prime could be at risk when using these drugs for anti-aging purposes.

The evidence comes from early-stage research involving mice, which means that while the findings are alarming, they are not yet confirmed in humans. The study highlights the need for caution as many individuals are experimenting with these drugs outside of clinical settings, often without medical supervision. Researchers are now investigating whether the damaged brain cells can recover and potentially lead to new insights into treating conditions like multiple sclerosis.

Given the current state of research, it is wise to approach the use of D+Q with caution. If you are considering any anti-aging treatments, consult with a healthcare professional to ensure you are making safe choices for your health.

Source: sciencedaily.com